Sort
82,697 grants matching “vaccine development”
Genetic and Biochemical Approaches to Tyrosine Kinase Function
$2,122,987Pamela Schwartzberg · National Human Genome Research Institute · ZIA · FY2010 · HG
Structure based design of antibodies and vaccines
$2,122,980James E Crowe · Vanderbilt University Medical Center · U19 · FY2017 · AI
Pathogenesis of E. coli and Shigella infections in human enteroid models
$2,122,332James B Kaper · University Of Maryland Baltimore · P01 · FY2025 · AI
The Gonorrhea Vaccine Cooperative Research Center
$2,121,697Ann E. Jerse · Henry M. Jackson Fdn For The Adv Mil/Med · U19 · FY2022 · AI
Small molecule stimulators of innate immune receptors
$2,120,235Dennis Carson · California Univ San Diego · N01 · FY2013 · AI
PRODUCTION OF A CHIMPANZEE ADENOVIRUS HIV-1 VACCINE
$2,120,046Phillip Ishikawa · Advanced Bioscience Laboratories, Inc. · N01 · FY2019 · AI
Development/production of H3/H1 influenza DNA plasmid vaccine
$2,119,938Kimberly Wallace · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Production of Alternate Adenovector Filovirus Vaccines
$2,119,938Kimberly Wallace · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Development/production of a Marburg rAd Vaccine
$2,119,937Kimberly Wallace · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
SPORE in Breast Cancer
$2,119,686Henry Shelton Earp · Univ Of North Carolina Chapel Hill · P50 · FY2009 · CA
SPORE in Breast Cancer
$2,119,685Henry Shelton Earp · Univ Of North Carolina Chapel Hill · P50 · FY2010 · CA
Chemical Biology Platforms to Define the Metabolism-Epigenetics Interface
$2,119,522Jordan Leslie Meier · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Immune Function and Biodefense in Children, Elderly, and the Immunocrompromised
$2,119,503Janko Nikolich-Zugich · Oregon Health & Science University · N01 · FY2010 · AI
Center for Population Health Research
$2,118,960Curtis William Noonan · University Of Montana · P20 · FY2020 · GM
Detection, prevention and treatment of acute myeloid leukemia (AML) relapse.
$2,117,028Christopher Hourigan · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL
Intracellular pathogens and innate immunity
$2,116,986Daniel A Portnoy · University Of California Berkeley · P01 · FY2017 · AI
SPORE in Breast Cancer
$2,116,400Henry Shelton Earp · Univ Of North Carolina Chapel Hill · P50 · FY2008 · CA
Characterization of novel genes encoded ty RNA and DNA viruses
$2,115,911Ralph S Baric · Univ Of North Carolina Chapel Hill · U19 · FY2015 · AI
Viral Hemorrhagic Fevers: Disease Modeling and Transmission
$2,115,203Heinrich Feldmann · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Disease Modeling of Influenza and Other Emerging Respiratory Viral Pathogens
$2,115,203Heinrich Feldmann · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Chicago Clinical Trials Unit
$2,115,008Babafemi O Taiwo · Northwestern University At Chicago · UM1 · FY2020 · AI
Pathogenesis of E. coli and Shigella infections in human enteroid models
$2,114,605James B Kaper · University Of Maryland Baltimore · P01 · FY2021 · AI
Vermont Immunobioloigy/ Infectious Diseases Center
$2,114,437Ralph C. Budd · University Of Vermont & St Agric College · P20 · FY2015 · GM
Protective immunity elicited by distinct polysaccharide antigens of classical and hypervirulent Klebsiella
$2,114,175David A. Rosen · Washington University · R01 · FY2025 · AI
Malaria Vaccine: BSAM
$2,113,978Louis Miller · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI